0.55Open0.55Pre Close0 Volume109 Open Interest17.00Strike Price0.00Turnover0.00%IV-2.81%PremiumNov 15, 2024Expiry Date1.00Intrinsic Value100Multiplier0DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma29.09Leverage Ratio--Theta--Rho--Eff Leverage--Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet